Arkolith/Insider Trading/BDTX/Form 4

Velleca Mark A.

PRESIDENT & CEO, DirectorBlack Diamond Therapeutics, Inc. (BDTX) · full profile →Form 4 · filed Sep 18, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 15, 2023Grant(A)5K$3.60$19K47K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 17, 2023Grant(A)1.0M—$01.0M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-23-013339) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML